Cbz-Dab(Fmoc)(Fmoc)-Asp(OtBu)(OtBu)-Phe-NH2 | 209269-95-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: Cbz-Dab(Fmoc)(Fmoc)-Asp(OtBu)(OtBu)-Phe-NH2
• 英文别名: tert-butyl (3S)-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-2-(phenylmethoxycarbonylamino)butanoyl]amino]-4-oxobutanoate
• CAS: 209269-95-4
• 化学式: C₄₄H₄₉N₅O₉
• 分子量: 791.901
• InChiKey: OICXYKMXXIRNLD-FSEITFBQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  58
• 可旋转键数：
  21
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  204
• 氢给体数：
  5
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  Cbz-Dab(Fmoc)(Fmoc)-Asp(OtBu)(OtBu)-Phe-NH2 、 N-{(S)-3-{[(Benzhydryl-carbamoyl)-methoxycarbonylmethyl]-carbamoyl}-3-[(S)-2-tert-butoxycarbonylamino-3-(4-hydroxy-phenyl)-propionylamino]-propyl}-succinamic acid 生成 tert-butyl (3S)-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-4-[[4-[[(3S)-4-[[2-[2-(benzhydrylamino)-2-oxoethoxy]-2-oxoethyl]amino]-3-[[(2S)-3-(4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]-4-oxobutyl]amino]-4-oxobutanoyl]amino]-2-(phenylmethoxycarbonylamino)butanoyl]amino]-4-oxobutanoate
  参考文献：
  名称：

  Modification of receptor selectivity and functional activity of cyclic cholecystokinin analogues

  摘要：

  We reported earlier on the synthesis and biological activity at the CCK-B receptor of cyclized derivatives of CCK. These peptides, in which the positions 28 and 31 were replaced by lysine residues, were bridged by a succinyl moiety. To determine the importance Of the nature and size of the cyclic structure, cyclic analogues were synthesized in which: (i) the lysine residues were replaced by ornithine and diaminobutyric acid and (ii) the succinic moiety was replaced by a malonic, adipic and glutaric moiety. They were tested for their ability to inhibit the specific binding of I-125-BH-CCK-8 to CCK receptors in rat pancreatic acini and guinea pig brain membranes. They were also evaluated for their ability to stimulate amylase secretion from rat pancreatic acini. The potency and selectivity of these analogues were compared with those obtained with CCK-4 and compound JMV320, a potent and selective CCK-B receptor ligand synthesized earlier in our laboratory. (C) Elsevier, Paris.

  DOI：

  10.1016/s0223-5234(98)80006-8
• 作为产物：
  描述：

  methyl (2S)-4-amino-2-{[(benzyloxy)carbonyl]amino}butanoate 在 sodium hydroxide 、 sodium carbonate 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 N,N-二异丙基乙胺 、 三氟乙酸 作用下， 以 1,4-二氧六环 、 甲醇 为溶剂， 反应 7.0h， 生成 Cbz-Dab(Fmoc)(Fmoc)-Asp(OtBu)(OtBu)-Phe-NH2
  参考文献：
  名称：

  Modification of receptor selectivity and functional activity of cyclic cholecystokinin analogues

  摘要：

  We reported earlier on the synthesis and biological activity at the CCK-B receptor of cyclized derivatives of CCK. These peptides, in which the positions 28 and 31 were replaced by lysine residues, were bridged by a succinyl moiety. To determine the importance Of the nature and size of the cyclic structure, cyclic analogues were synthesized in which: (i) the lysine residues were replaced by ornithine and diaminobutyric acid and (ii) the succinic moiety was replaced by a malonic, adipic and glutaric moiety. They were tested for their ability to inhibit the specific binding of I-125-BH-CCK-8 to CCK receptors in rat pancreatic acini and guinea pig brain membranes. They were also evaluated for their ability to stimulate amylase secretion from rat pancreatic acini. The potency and selectivity of these analogues were compared with those obtained with CCK-4 and compound JMV320, a potent and selective CCK-B receptor ligand synthesized earlier in our laboratory. (C) Elsevier, Paris.

  DOI：

  10.1016/s0223-5234(98)80006-8

文献信息

• Modification of receptor selectivity and functional activity of cyclic cholecystokinin analogues
  作者：Muriel Amblard、Marc Rodriguez、Marie-Françoise Lignon、Marie-Christine Galas、Nicole Bernad、André Aumelas、Jean Martinez

  DOI：10.1016/s0223-5234(98)80006-8

  日期：1998.3

  We reported earlier on the synthesis and biological activity at the CCK-B receptor of cyclized derivatives of CCK. These peptides, in which the positions 28 and 31 were replaced by lysine residues, were bridged by a succinyl moiety. To determine the importance Of the nature and size of the cyclic structure, cyclic analogues were synthesized in which: (i) the lysine residues were replaced by ornithine and diaminobutyric acid and (ii) the succinic moiety was replaced by a malonic, adipic and glutaric moiety. They were tested for their ability to inhibit the specific binding of I-125-BH-CCK-8 to CCK receptors in rat pancreatic acini and guinea pig brain membranes. They were also evaluated for their ability to stimulate amylase secretion from rat pancreatic acini. The potency and selectivity of these analogues were compared with those obtained with CCK-4 and compound JMV320, a potent and selective CCK-B receptor ligand synthesized earlier in our laboratory. (C) Elsevier, Paris.